Decreased motoneuron survival in Igf2 null mice after sciatic nerve transection

Delia Silva1, Pieter Dikkes, Medina Barnes

  • 1Endocrine Division Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Neuroreport
|September 10, 2009
PubMed

Insights

Insulin-like growth factor 2 (IGF2) is crucial for protecting neonatal motor neurons from injury-induced death. Studies show that IGF2 deficiency increases motor neuron damage, while IGF2 administration improves survival.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Developmental Biology

Background:

  • Neurotrophic factors are essential for neuronal survival.
  • Insulin-like growth factor 2 (IGF2) exhibits neurotrophic properties.
  • Understanding IGF2's role in motor neuron survival is critical for therapeutic development.

Purpose of the Study:

  • To investigate the role of Insulin-like growth factor 2 (IGF2) in neonatal motor neuron survival following axonal injury.
  • To determine if IGF2 deficiency exacerbates motor neuron damage.
  • To assess the neuroprotective effects of IGF2 administration.

Main Methods:

  • Utilized Igf2 knockout (Igf2) neonate mice models.
  • Induced axonal injury via sciatic nerve transection.
  • Quantified motor neuron survival rates.
  • Administered IGF2 to assess its therapeutic potential.

Main Results:

  • Igf2 knockout mice exhibited increased susceptibility to motor neuron damage compared to wild-type mice.
  • A significantly lower percentage of motor neuron survival was observed in Igf2 deficient neonates after sciatic nerve injury.
  • IGF2 administration significantly improved neuronal survival in Igf2 knockout mice.

Conclusions:

  • IGF2 plays a vital role in the survival of neonatal motor neurons after axonal injury.
  • IGF2 deficiency is detrimental to motor neuron survival.
  • IGF2 represents a potential therapeutic target for preventing motor neuron death.

Related Concept Videos